Viral Gastroenteritis Market
The business research firm’s global market report has now been updated with the latest market size information for 2023 and forecast 2032
Business Research’s Viral Gastroenteritis Global Market Report 2023 states that the increasing prevalence of gastrointestinal diseases is the key driver for the growth of the viral gastroenteritis market during the forecast period. Gastrointestinal (GI) disease refers to diseases that occur in or in any part of the gastrointestinal tract. Viral gastroenteritis medications and diagnostic treatments can help people with this disease take appropriate and appropriate medication.
The global viral gastroenteritis market is expected to grow from US$5.99 billion in 2022 to US$6.34 billion in 2023, at a compound annual growth rate (CAGR) of 6%. The Russia-Ukraine war undermines the global economy’s chances of recovering from the COVID-19 pandemic. The war between the two countries has resulted in economic sanctions on many countries, soaring commodity prices and disrupted supply chains, leading to inflation of goods and services, affecting many markets around the world. The viral gastroenteritis market is expected to reach US$7.68 billion by 2027, growing at a CAGR of 4.9%.
Download Free Sample of Viral Gastroenteritis Market Report – https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp
Key competitors in the viral gastroenteritis market include Pfizer, AbbVie, Bayer, Sanofi, and AstraZeneca.
A major trend in the viral gastroenteritis market includes product innovation. Major companies in the viral gastroenteritis market are focusing on developing new products to strengthen their position in the market. For example, in November 2022, the British biopharmaceutical company GlaxoSmithKline plc’s ROTARIX oral administration applicator (liquid formulation) was approved by the U.S. Food and Drug Administration (FDA) for the prevention of whorls in infants. Viral gastroenteritis. This new presentation formulation eliminates the need to reconstitute vaccine doses upon use, making it more convenient for healthcare providers. The approval was supported by international clinical trial data demonstrating safety and tolerability as well as non-inferiority in immunogenicity compared to the lyophilized formulation.
Read more about the global viral gastroenteritis market report here:
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report
Viral Gastroenteritis Market Segmentation –
1. Classification by drug: antibiotics, antacids, laxatives, antimotility agents, other drugs
2. Diagnosis by: physical examination, rapid stool test
3. Classification by indication: watery diarrhea, abdominal cramps, pain, other indications
4. By virus type: norovirus, rotavirus, astrovirus, enteric adenovirus
5. By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Other End Users
6. By region: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America is the largest region for the viral gastroenteritis market.
Business Research Company’s Global Viral Gastroenteritis Market Report 2023 provides a comprehensive understanding of 60 regional markets. The report covers market size, growth rate, segments, drivers, and trends for each region and country. Additionally, the report provides insights on historical and forecast growth to help players better analyze and strategize.
Explore viral gastroenteritis market report buying options here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127
The catalog of viral gastroenteritis market includes:
1.executive Summary
2. Viral gastroenteritis market characteristics
3. Viral Gastroenteritis Market Trends and Strategies
4. Viral Gastroenteritis Market – Macroeconomic Scenario
…
32. Global Viral Gastroenteritis Market Competitive Benchmarks
33. Global Viral Gastroenteritis Market Competition Dashboard
34. Key mergers and acquisitions in the viral gastroenteritis market
35. Future prospects and potential analysis of viral gastroenteritis market
36. Appendix
contact us:
business research company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
follow us:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
Youtube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global market model: https://www.thebusinessresearchcompany.com/global-market-model
The latest popular press releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want to learn more about Business Research Company?
Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence company and a pioneer in company, market and consumer research. TBRC has consultants located around the world specializing in a variety of industries, including manufacturing, healthcare, financial services, chemicals and technology.
Global Market Model – the world’s most comprehensive database
The business research firm’s flagship global market model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and indicators across 60 regions and 27 industries. The global market model covers multi-layered data sets to help users assess supply and demand gaps.
This version is published on openPR.